Greenhouse Gas Accounting Sector Guidance for Pharmaceutical Products and Medical DevicesA consortium of major global companies has been working with the NHS SDU to agree standards for reporting of…
David Pencheon has been quoted recently as seeing opportunity in the disruption caused by the passing of the Health and Social Care Act.
With new commissioning groups forming, priorities and visions…
Not sure whether people have seen this article in the Guardian:
http://www.guardian.co.uk/society/2012/jul/03/prescription-medicine-unused?INTCMP=SRCH
Regards,
Mark
The Centre's Sustainable Respiratory Care group will lead research on why the UK continues to use inhalers with a much higher carbon footprint than other European countries. 25,000 people a year die…
On the 23rd of March I was lucky to be among a group of respiratory professionals, representatives from primary care, nursing, academic and the pharmaceutical industry as we came together to discuss…
A little while ago GlaxoSmithKline funded a joint study with the Smith School of Enterprise and the Environment, University of Oxford and Accenture. The outcome was a report entitled "Climate Change…
Value is a concept which is making waves in the management / leadership / policy world of medicine at the moment. It is not an entirely new concept, but has been worked on and promoted as an approach…
In February 2011 GlaxoSmithKline and the Cooperative Pharmacy in partnership with TerraCycle UK launched the first respiratory inhaler recycling programme in Europe. Forty Cooperative pharmacies…
What will respiratory medicine look like in 5 years’ time, when carbon rationing is re-shaping the NHS?We are starting an exciting project, funded for a year by GSK, to improve the environmental…
What will respiratory medicine look like in 5 years’ time, when carbon rationing is re-shaping the NHS?We are starting an exciting project, funded for a year by GSK, to improve the environmental…